Guerrera Ida Chiara, Quetier Ivan, Fetouchi Rachid, Moreau Frederique, Vauloup-Fellous Christelle, Lekbaby Bouchra, Rousselot Caroline, Chhuon Cerina, Edelman Aleksander, Lefevre Marine, Nicolas Jean-Claude, Kremsdorf Dina, Lacau Saint Guily Jean, Soussan Patrick
Plateau Protéome Necker, IFR 94, Université Paris Descartes , Paris, France.
J Proteome Res. 2014 Feb 7;13(2):1002-11. doi: 10.1021/pr401009f. Epub 2014 Jan 10.
The prevalence of head and neck squamous cell carcinoma (HNSCC) related to human papillomavirus (HPV) is increasing, unlike tobacco- and alcohol-associated cancers. To gain a clearer understanding of the molecular mechanisms implicated in HNSCC, depending on the presence or not of a viral sequence, we investigated the expression of proteins detected in the tumor regions of HNSCC patients. Twenty-two untreated HNSCC patients were selected according to the presence of HPV-16. For six patients, tumor and controlateral healthy tissues were tested for viral detection before quantitative proteomic analysis. After confirmation by Western blot, proteins were connected into a network, leading to investigate interleukin-6 (IL-6) by immunocytochemistry and ELISA. 41 ± 5% of proteins quantified by proteomics were differentially expressed in tumor compared with healthy regions. Among them, 36 proteins were retained as modulated in HPV-16 positive or negative tumors, including cytokeratins, tubulins, annexin A1, and serpin B1. Network analysis suggested a central role of IL-6, confirmed by overexpression of IL-6 in tumor tissues as in sera of HPV-negative HNSCC compared with HPV-16-positive tumors. This modulation may contribute to the survival and proliferation of cancer cells, although it was not related to tumor stage or to the level of HPV-16 DNA.
与人类乳头瘤病毒(HPV)相关的头颈部鳞状细胞癌(HNSCC)的患病率正在上升,这与烟草和酒精相关癌症的情况不同。为了更清楚地了解与HPV存在与否相关的HNSCC的分子机制,我们研究了在HNSCC患者肿瘤区域检测到的蛋白质表达情况。根据HPV - 16的存在情况,选择了22例未经治疗的HNSCC患者。对于6例患者,在进行定量蛋白质组分析之前,对肿瘤组织和对侧健康组织进行了病毒检测。经蛋白质免疫印迹法确认后,将蛋白质连接成网络,进而通过免疫细胞化学和酶联免疫吸附测定法研究白细胞介素 - 6(IL - 6)。通过蛋白质组学定量的蛋白质中有41±5%在肿瘤组织中与健康区域相比存在差异表达。其中,36种蛋白质在HPV - 16阳性或阴性肿瘤中被确定为有调节作用,包括细胞角蛋白、微管蛋白、膜联蛋白A1和丝氨酸蛋白酶抑制剂B1。网络分析表明IL - 6起核心作用,与HPV - 16阳性肿瘤相比,HPV阴性HNSCC患者肿瘤组织和血清中IL - 6的过表达证实了这一点。这种调节可能有助于癌细胞的存活和增殖,尽管它与肿瘤分期或HPV - 16 DNA水平无关。